|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.05 CNY | +1.33% |
|
+5.59% | +9.41% |
| Apr. 24 | Huahai Pharmaceutical Gets Approval to Market Busulfan Injection | MT |
| Apr. 19 | Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 14, 2023. | CI |
Zhejiang Huahai Pharmaceutical Co., Ltd. (SHSE:600521) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its common stock. The shares will be repurchased at a price of CNY 24.49 per share.
The shares will be funded from company?s own funds. The share repurchase is intended to be used for equity incentives or employee stock ownership plans. The program will be valid for 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| +9.41% | 3.26B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. 
